TABITUXIMAB BARZUXETAN YTTRIUM Y-90
UNII 1Q6DY14GVO

Substance Identification & Data

This profile provides standardized clinical and technical data for Tabituximab Barzuxetan Yttrium Y-90, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 1Q6DY14GVO.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number N/A and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
1Q6DY14GVO
CAS Registry Number
N/A
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
TABITUXIMAB BARZUXETAN YTTRIUM Y-90
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
INN ID
10232
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Tabituximab Barzuxetan Yttrium Y-90. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

90Y-OTSA-101
ANTI-FZD10 ADCC ENHANCED ANTIBODY (OTSA101) YTTRIUM Y-90
TABITUXIMAB BARZUXETAN YTTRIUM Y-90
YTTRIUM Y-90 LABELED IMMUNOGLOBULIN G1, ANTI-(FRIZZLED RECEPTOR FRIZZLED-10) (HUMAN-MUS MUSCULUS MONOCLONAL OTSA101 HEAVY CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL OTSA101 LIGHT CHAIN, DIMER, COMPD. WITH N-((1S,2S)-2-(BIS(CARBOXYMETHYL)AMINO)CYCLOHEXYL)-N-((2R)-2-(BIS(CARBOXYMETHYL)AMINO)-3-(4-ISOTHIOCYANATOPHENYL)PROPYL)GLYCINE

Technical Codes

OTSA-101-DTPA YTTRIUM Y-90
YTTRIUM 90-RADIOLABELLED OTSA 101